3D Bioprinted Omentum tissue to model ovarian cancer metastasis
3D Bioprinted Omentum tissue to model ovarian cancer metastasis
批准号:
10683668
负责人:
Marc Ferrer
金额:
$90.89万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
3-DimensionalAnimal ModelAntineoplastic AgentsBiological AssayBlood VesselsCancer Cell GrowthCell LineCell modelCell-Matrix JunctionCellsDevelopmentEndothelial CellsFibroblastsFluorescence MicroscopyFunctional disorderGenetically Engineered MouseGoalsGrowthHumanImmunodeficient MouseIn VitroLabelLocationMalignant NeoplasmsMalignant neoplasm of ovaryMesothelial CellMetastatic Malignant Neoplasm to the OvaryModelingMonitorMorphologyNeoplasm MetastasisOmentumPatientsPericytesPhysiologicalPhysiologyPreclinical TestingProductionProtocols documentationSiteSurfaceSuspensionsThree-Dimensional ImagingTissuesToxicity TestsXenograft procedurebiofabricationbioprintingcancer cellcell growthcellular imagingclinical efficacydrug developmentdrug discoveryefficacy testingmonolayerneoplastic cellnovel therapeuticsovarian neoplasmpredictive testpreventscreeningtumor
中文摘要
我们已经开发了一种生物制造方案,用于生产包括患者来源的成纤维细胞、内皮细胞和周细胞以及一层患者间皮细胞的血管化大网膜模型。患者细胞来自我们的合作者Ernst Lengyel博士和Hilary Kenny博士。将荧光标记的卵巢肿瘤细胞悬液添加到组织上的间皮细胞层的顶部,并使用荧光显微镜监测组织内的肿瘤形成。3D成像分析已经被开发出来,以量化肿瘤的大小和数量以及它们的位置。这些分析将被用来筛选一组有针对性的化合物,以防止组织中的肿瘤形成。
英文摘要
We have developed biofabrication protocols for the production of a vascularized omentum model that includes patient derived fibroblasts, endothelial cells and pericytes, and a layer of patient mesothelial cells. Patient cells were obtained from our collaborators Dr. Ernst Lengyel and Hilary Kenny. Addition of a suspension of fluorescently labeled ovarian tumor cells to the top of mesothelial cell layer on the tissue and used fluorescence microscopy to monitor tumor formation inside the tissue. 3D imaging analysis have been developed to quantiate size and number of tumors, and their location. These analytics will be used to screen a focused set of compounds for compounds that prevent tumor formation in the tissue.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Identification of novel agonist of the Relaxin family peptide receptor 2 (RXFP2) as potential new therapeutics for testicular maldescent
-
批准号:9205645
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
3D Bioprinted retina models for drug screening
-
批准号:10916043
-
项目类别:
-
资助金额:$226.91万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
3D Bioprinted lung cancer models for drug screening
-
批准号:10907367
-
项目类别:
-
资助金额:$226.91万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Targeting Tumor-derived exRNA-Containing microvesicles by high throughput screening
-
批准号:9359917
-
项目类别:
-
资助金额:$15.8万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of Small Molecule Effectors that target the Fungal-Specific Kinase Drk1 as Novel Antifungal Drug Leads
-
批准号:9205652
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
3D Bioprinting of human native-like tissues as disease-in-a-dish models for drug discovery
-
批准号:9355001
-
项目类别:
-
资助金额:$301.07万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
PAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress
-
批准号:9360500
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Small molecule inhibitor screen of MHC II processing pathways using influenza virus A/PR/8/34
-
批准号:9205649
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of Small Molecule Inhibitors of PHF5A for Glioblastoma
-
批准号:9360504
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
High-throughput screens for compounds that reverse cellular toxicity of neurodegenerative disease-associated proteins in yeast models (alpha-synuclein)
-
批准号:9205648
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
A drug-screening platform for autism spectrum disorders using human neurons and astrocytes
-
批准号:9205632
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
HTS screening for inhibitors of HPV 16 E6/caspase 8 binding
-
批准号:9205653
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of GPR52 antagonists as potential treatments for Huntington Disease
-
批准号:9205646
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of small molecule inhibitors of miR-155 expression in Th17 cells
-
批准号:9205636
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Adaptation of an Organotypic 3 Dimensional Culture for High-Throughput Screening
-
批准号:9205647
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
3D Bioprinted skin models for drug screening
-
批准号:10683670
-
项目类别:
-
资助金额:$90.89万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses
-
批准号:10907368
-
项目类别:
-
资助金额:$10.18万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of small molecule inhibitors of Neutral Sphingomyelinase 2 (nSMase2) as a new therapeutic approach for the treatment of neurodegenerative disorders
-
批准号:9360493
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
A Novel Cell-Based Assay to Identify Small Molecules for Galactocerebrosidase (GALC)
-
批准号:9360503
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of small molecules that decrease the activity of the huntingtin gene promoter for the potential treatment of Huntington Disease
-
批准号:9205664
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
海外基金